Adjuvant mitotane treatment for adrenocortical carcinoma
about
Systemic therapy of Cushing's syndromeSafety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinomaTreatment of Cushing disease: overview and recent findingsAdrenocortical carcinoma (ACC): diagnosis, prognosis, and treatmentAnalysis of the role of Igf2 in adrenal tumour development in transgenic mouse modelsAdrenal masses: A urological perspectiveMetformin as a new anti-cancer drug in adrenocortical carcinomaPrediction of cancer drugs by chemical-chemical interactionsThe efficacy of radiation therapy in adrenocortical carcinoma: A propensity score analysis of a population-based studyAdrenocortical carcinoma secreting cortisol, androgens and aldosterone: a case report.Transcutaneous biopsy of adrenocortical carcinoma is rarely helpful in diagnosis, potentially harmful, but does not affect patient outcome.Adrenocortical carcinoma with skeletal metastases in a postmenopausal woman.Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan.How is adrenocortical cancer being managed in the UK?Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.Deficits in the management of patients with adrenocortical carcinoma in Germany.Adrenocortical carcinoma mimicking lung cancer and responding to vinorelbine/carboplatin and pemetrexed/carboplatin.Emerging therapy for adrenocortical carcinoma.Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome)Therapy of adrenocortical cancer: present and future.Giant adrenal pseudocyst harbouring adrenocortical cancer.Nonfunctional adrenocortical carcinoma initially presenting as retroperitoneal hemorrhage.Current and emerging therapies for advanced adrenocortical carcinoma.Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care centerSurvival and prognostic factors for adrenocortical carcinoma: a single institution experience.Virilizing adrenocortical carcinoma advancing to central precocious puberty after surgery.A case report of a solitary pancreatic metastasis of an adrenocortical carcinoma.Liver resection and ablation for metastatic adrenocortical carcinomaA rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old male.Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States.Adrenocortical carcinoma: the management of metastatic disease.Androgen secreting giant adrenocortical carcinoma with no metastases: A case report and review of the literature.Current and emerging therapeutic options in adrenocortical cancer treatment.Management Strategies for Aggressive Cushing's Syndrome: From Macroadenomas to EctopicsEffects of increased cross-sectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: analysis of the National Cancer Database.Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical TumorsAdrenocortical Carcinoma: Current Therapeutic State-of-the-Art.Adrenohepatic fusion: Adhesion or invasion in primary virilizant giant adrenal carcinoma? Implications for surgical resection. Two case report and review of the literature.A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinomaEvaluation of 9-cis retinoic acid and mitotane as antitumoral agents in an adrenocortical xenograft model.
P2860
Q22000607-051E1C9D-3AB3-4614-AA4F-377BC46026FBQ24607285-5E945CF1-220F-49B7-94FA-ED890B10AC72Q24626819-D868C316-8731-41EF-A06A-570B96DC87DCQ26801839-1AF8E2D5-B78B-4865-88CE-6BF528D253EFQ27321080-78FEDB9E-4E38-417C-AAB2-87B262DD77A6Q28072224-8C8C1559-AE11-4F2F-8416-9B2412116726Q28468634-9E3E2AB5-79AB-4C51-81EF-E144EB7152CAQ28539449-7962B6DC-91E3-4192-BC7B-2EA80EECF080Q33627211-4782A78B-8F27-4221-9938-F4C63B0D8A86Q33681621-76712589-3714-4799-A411-FA67235C2482Q33896706-F4CDA54D-FD08-4535-9883-F9DD8A84C670Q33985510-7922C5F1-D3DE-4105-9A5A-F4BB658569B1Q34173001-E39C95E6-EB93-4F05-8EEA-88DF9FAAC1B4Q34251801-F092F09B-C531-4D76-8AA8-210316C9A4B5Q34431264-7C31ADCB-9477-4288-A2B6-A3CA2DD1EFA4Q34495638-881A1238-9F00-4854-B02C-7AA0C4850CD2Q34572924-443E17D2-7662-4F19-8E6D-2E30C88B5184Q35018399-4F6E4018-6883-4D14-98F4-03F4CDE13D1DQ35095366-AA5CDFAD-468E-4BC2-B797-B7660DE9E036Q35232257-687D94D7-A9D2-4F97-BA34-AC67E1AE6ECDQ35258767-531A59E3-2F33-47CC-9DA3-E1BC77A17F1DQ35538003-85FB3AAD-073F-41D1-B549-E8A2A8F914F1Q35584305-7BED9680-9A8F-439F-8B86-FA9AB2329A66Q35636134-E04BA424-227D-46DC-8DCB-798873DD42A2Q35642478-21D5E471-96FA-4832-98A9-E7D9E6DA43C8Q35651305-D8AA4521-6857-4150-9484-7C83BEF15615Q35727399-D4B03A54-193D-4BFC-87EA-EFEB2A955F4AQ35738507-33227067-F8B0-4812-B6EF-C7483D8C3178Q35765544-0967852D-1BC4-40C2-B401-CD2BA4208CC1Q35889904-55F7F34B-E86A-479C-8C65-9EE3E80C4486Q36081865-370285FE-CB37-4695-85A2-6BA7713331F0Q36090257-E99B9332-7426-4255-9586-C7FA27BFF113Q36183873-9C499E3E-247D-4FFF-85BB-B1E541CAC1A1Q36184067-A7CE198E-8959-45A9-82FC-28A41E1418FDQ36206068-FB19349F-774C-4C4F-AFBA-93E218FF1836Q36240937-D61DE11F-2FAC-4BBE-89D1-F7922CEEE736Q36355661-54691D6E-76CC-417D-9056-6F0C55FBC693Q36431728-7E10471B-9FA3-4EB7-A878-2F705F8D354EQ36508877-DF561EBA-7969-4C80-BF64-631A321FCF13Q36516597-26410EA0-6C29-4A61-80EC-595EC50966FC
P2860
Adjuvant mitotane treatment for adrenocortical carcinoma
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Adjuvant mitotane treatment for adrenocortical carcinoma
@ast
Adjuvant mitotane treatment for adrenocortical carcinoma
@en
Adjuvant mitotane treatment for adrenocortical carcinoma
@nl
type
label
Adjuvant mitotane treatment for adrenocortical carcinoma
@ast
Adjuvant mitotane treatment for adrenocortical carcinoma
@en
Adjuvant mitotane treatment for adrenocortical carcinoma
@nl
prefLabel
Adjuvant mitotane treatment for adrenocortical carcinoma
@ast
Adjuvant mitotane treatment for adrenocortical carcinoma
@en
Adjuvant mitotane treatment for adrenocortical carcinoma
@nl
P2093
P50
P3181
P356
P1476
Adjuvant mitotane treatment for adrenocortical carcinoma
@en
P2093
Alberto Angeli
Alfredo Berruti
Ann-Cathrin Koschker
Bruno Allolio
Bruno Ambrosi
Erika Grossrubatscher
Franco Mantero
Fulvia Daffara
Libuse Tauchmanova
P304
P3181
P356
10.1056/NEJMOA063360
P407
P50
P577
2007-06-07T00:00:00Z